Effect of BIA 6-512 at Steady-state on the Levodopa Pharmacokinetics

NCT03094156 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: Placebo
DRUG: BIA 6-512
DRUG: Madopar® 250
DRUG: Comtan®

Sponsor

Bial - Portela C S.A.